YOLFTbeta
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

002864 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

22.08CNY-0.90 (-3.92%)

Price History

Full chart

Market Stats

Previous Close22.98
Open22.30
Day Range21.86 – 23.60
52-Week Range18.69 – 32.45
Volume13.33M
Market Cap2.88B
P/E (TTM)36.31
Forward P/E0.00
EPS0.58
Dividend Yield1.67%
Beta-0.27
50-Day Avg21.51
200-Day Avg23.86

About

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula granules in China. The company offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. It also offers health food, health products, functional health food, and daily chemical products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is headquartered in Xi'an, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Dezhu Zhang
  • Employees926
  • HeadquartersNo. 2801, Baliu 2nd Road, Xi'an, China, 710025, China
  • Websitehttps://www.pljt.com

Leadership

  • Mr. Dezhu ZhangPresident, VP & Director · b. 1976
  • Mr. Fengming ZhuChief Financial Officer · b. 1971
  • Mr. Zhong MengVice President & Director · b. 1983
  • Mr. Jilin HuangVP & Director · b. 1983
  • Qian ChengAccounting Supervisor
  • Mr. Qingshui LuoDirector of Legal Department · b. 1961

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue226.61M245.70M256.10M305.43M376.79M489.45M610.64M670.31M887.48M974.29M980.83M973.86M1.14B
Growth (%)-+8.42%+4.23%+19.26%+23.37%+29.90%+24.76%+9.77%+32.40%+9.78%+0.67%-0.71%+17.15%
Cost of Revenue69.85M72.31M90.49M113.01M115.93M141.21M187.84M255.52M370.36M408.25M413.74M381.74M549.08M
Gross Profit156.76M173.39M165.60M192.42M260.86M348.23M422.80M414.79M517.12M566.04M567.09M592.12M591.79M
Gross Margin69.18%70.57%64.66%63.00%69.23%71.15%69.24%61.88%58.27%58.10%57.82%60.80%51.87%
Operating Expense122.48M129.94M117.31M148.02M210.74M282.07M336.44M319.81M404.60M443.02M432.23M453.76M469.51M
Operating Income34.28M43.45M48.29M44.40M50.12M66.17M86.35M94.98M112.53M123.02M134.86M138.37M122.28M
Operating Margin15.13%17.68%18.86%14.54%13.30%13.52%14.14%14.17%12.68%12.63%13.75%14.21%10.72%
EBITDA75.75M50.95M54.63M55.82M61.77M87.22M96.84M111.95M127.47M150.30M165.29M171.01M147.95M
EBITDA Margin33.43%20.74%21.33%18.28%16.39%17.82%15.86%16.70%14.36%15.43%16.85%17.56%12.97%
Net Income32.89M40.07M42.64M39.53M43.72M64.68M71.78M79.12M93.17M101.16M110.43M120.27M96.28M
Net Income Margin14.52%16.31%16.65%12.94%11.60%13.22%11.75%11.80%10.50%10.38%11.26%12.35%8.44%
R&D2.31M8.03M7.73M5.42M7.23M8.29M13.08M12.97M14.03M18.23M20.26M37.54M53.11M
R&D as % of Total Revenue1.02%3.27%3.02%1.77%1.92%1.69%2.14%1.94%1.58%1.87%2.07%3.85%4.66%
Interest Expense1.14M3.04M1.43M1.38M410.42K67.59K111.75K3.01M3.70M14.06M6.23M1.56M2.18M
Interest Expense % of Total Revenue0.50%1.24%0.56%0.45%0.11%0.01%0.02%0.45%0.42%1.44%0.64%0.16%0.19%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets342.39M401.26M433.33M504.50M752.93M817.84M928.88M1.16B1.33B1.93B2.13B2.28B2.32B
Total Liabilities131.55M155.06M144.44M176.68M197.34M206.24M254.17M426.89M522.97M983.18M573.76M642.84M633.75M
Total Equity211.53M245.62M288.25M327.82M555.58M611.60M674.71M720.78M791.38M929.65M1.55B1.64B1.69B
Cash67.79M105.13M80.48M125.67M301.47M85.12M117.68M382.00M419.30M823.44M1.10B1.17B1.09B
Total Debt20.00M40.00M20.00M20.00M3.00M--106.95M143.90M427.16M102.49M150.83M-
Net Debt-47.79M-65.13M-60.48M-105.67M-298.47M-85.12M-117.68M-318.66M-312.61M-429.74M-999.52M-1.02B-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.43M48.56M40.62M61.99M28.45M46.85M67.89M92.24M116.04M125.36M104.05M156.59M63.01M
Investing Cash Flow-33.80M-29.62M-43.88M-10.46M-20.49M-246.68M-26.66M169.84M-85.75M-37.57M-62.41M-103.51M-
Financing Cash Flow-742.77K18.41M-21.39M-6.34M167.85M-16.52M-8.67M2.24M7.01M316.35M236.93M14.28M-
Capital Expenditure30.55M32.42M45.08M17.06M23.45M20.06M33.55M71.18M80.68M55.84M62.51M82.05M42.41M
Free Cash Flow-5.12M16.13M-4.46M44.94M5.00M26.78M34.34M21.06M35.36M69.53M41.53M74.54M20.60M
Dividends Paid1.80M1.59M1.39M1.34M358.87K8.67M8.67M13.00M17.89M21.09M24.30M24.52M43.89M
FCF to OCF-20.12%33.22%-10.97%72.49%17.58%57.17%50.58%22.83%30.47%55.46%39.92%47.60%32.70%
Dividend Paid to FCF-35.24%9.85%-31.17%2.99%7.18%32.36%25.24%61.74%50.60%30.33%58.50%32.90%213.03%

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 25, 2020Oct 27, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 21, 2024May 21, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------
EPS Actual0.090.090.180.140.160.110.230.180.120.110.260.390.120.210.220.280.180.180.220.290.210.170.260.220.220.300.210.220.230.300.210.220.050.160.15
Surprise-----------------------------------
Timing------------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.88B
Enterprise Value1.76B
Trailing P/E36.31
Forward P/E0.00
Price / Sales2.91
Price / Book1.67
EPS0.58
Book Value12.52
Revenue (TTM)989.42M
Gross Profit (TTM)542.17M
EBITDA119.29M
Profit Margin7.94%
Operating Margin11.52%
Return on Equity4.60%
Return on Assets2.14%
Shares Outstanding136.70M
Shares Float85.19M
Beta-0.27
Dividend Yield1.67%
Dividend Rate0.35
Payout Ratio60.61%

Dividends

20263×
0.05Nov 11, 20260.10Sep 16, 20260.25Jul 22, 2026
20253×
0.08Sep 16, 20250.19May 29, 20250.04Feb 17, 2025
20241×
0.17Jun 3, 2024
20231×
0.15May 31, 2023
20221×
0.14May 31, 2022
20211×
0.12May 31, 2021
20201×
0.12Jun 10, 2020
20191×
0.08May 30, 2019
20181×
0.08May 22, 2018

Stock Splits

  • Jul 22, 20261.3:1